You are here

  • Home
  • Archive
  • Volume 11, Issue 7
  • Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

Authors

  • Jia-Yi Deng Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaSchool of Medicine, South China University of Technology, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qing Gou Department of Interventional Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Lingling Yang Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, China PubMed articlesGoogle scholar articles
  • Zhi-Hong Chen Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ming-Yi Yang Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaSchool of Medicine, South China University of Technology, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xiao-Rong Yang Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaSchool of Medicine, South China University of Technology, Guangzhou, China PubMed articlesGoogle scholar articles
  • Hong-Hong Yan Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xue-Wu Wei Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaSchool of Medicine, South China University of Technology, Guangzhou, China PubMed articlesGoogle scholar articles
  • Jia-Qi Liu Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Jian Su Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Wen-Zhao Zhong Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Chong-Rui Xu Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yi-Long Wu Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qing Zhou Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles

Citation

Deng J, Gou Q, Yang L, et al
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2023;11:e007218. doi: 10.1136/jitc-2023-007218
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.